跳至主要内容
临床试验/NCT00169286
NCT00169286已完成不适用

Organized Self-management Support for Chronic Depression

Kaiser Permanente2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2003年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
104
试验地点
2
主要终点
feasibility and acceptability (including recruitment, intervention uptake and continued participation) of the intervention programs

研究概览

简要总结

This study aims to adapt and pilot test two core elements of an organized care program (systematic telephone outreach and monitoring to improve quality and continuity of pharmacotherapy, and structured psychoeducational group programs focused on patient activation and self-management) in a population-based sample of patients with chronic or recurrent depression.

详细描述

This study aims to adapt and pilot test two core elements of an organized care program (systematic telephone outreach and monitoring to improve quality and continuity of pharmacotherapy, and structured psychoeducational group programs focused on patient activation and self-management) in a population-based sample of patients with chronic or recurrent depression. Two forms of group self-management training will be evaluated: a Peer-Led Chronic Disease Self-Management Group (after that developed by Lorig and colleagues) and a Therapist-Led Cognitive-Behavioral Therapy Group. Approximately 100 patients with chronic or recurrent depression were randomly assigned to one of four conditions: 1) usual care; 2) phone care management; 3) phone care management plus peer-led self-management group; or 4) phone care management plus therapist-led CBT group. Blinded assessments will examine clinical outcomes (SCL depression score, depression diagnosis by SCID), functional outcomes, and process variables (self-efficacy for managing depression, use of coping strategies) over 12 months. If patients choose not to participate in treatment, reasons for dropout were assessed. The data collected will provide:1) an evaluation of the feasibility and acceptability (including recruitment, intervention uptake and continued participation) of the intervention programs; 2) preliminary evaluation of effectiveness, i.e., the effects of each intervention on patient outcomes and process of care; and 3) information to inform the design and implementation of a full-scale effectiveness trial (refinement of intervention programs and measurement strategy, necessary sample size).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Other
盲法
Single

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • history of at least one major depression in the last two years
  • history of recurent major depression or dysthymia
  • significant residual symptoms after 6 months of treatment

排除标准

  • history of mania or hypomania
  • cognitive impairment
  • near-terminal medical illness
  • intent to disenroll from health plan
  • emergent clinical needs

结局指标

主要结局

feasibility and acceptability (including recruitment, intervention uptake and continued participation) of the intervention programs

次要结局

  • clinical outcomes (SCL depression score, depression diagnosis by SCID), functional outcomes (SF-36 Questionnaire, and process variables (self-efficacy for managing depression)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

已完成
3 期
Organized Self-Management Support Services for Chronic DepressionDepression
NCT01139060Kaiser Permanente302
已完成
不适用
Active Living Tool Kit for Chronic ConditionsChronic Diseases
NCT01832064Stanford University255
已完成
不适用
Developing a Self-Management Program for People With Depression and Chronic Medical IllnessDepression
NCT00523029University of Southern California104
已完成
不适用
A Self-Management Program for Adults With Both Schizophrenia and a Co-occurring Medical ConditionSchizophrenia
NCT00525304University of Maryland, Baltimore100
已完成
不适用
Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck CancerCaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage I Hypopharyngeal Squamous Cell CarcinomaStage I Laryngeal Squamous Cell CarcinomaStage I Lip and Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell CarcinomaStage II Hypopharyngeal Squamous Cell CarcinomaStage II Laryngeal Squamous Cell CarcinomaStage II Lip and Oral Cavity Squamous Cell CarcinomaStage II Oropharyngeal Squamous Cell CarcinomaStage III Hypopharyngeal Squamous Cell CarcinomaStage III Laryngeal Squamous Cell CarcinomaStage III Lip and Oral Cavity Squamous Cell CarcinomaStage III Oropharyngeal Squamous Cell CarcinomaStage IV Hypopharyngeal Squamous Cell CarcinomaStage IV Laryngeal Squamous Cell CarcinomaStage IV Lip and Oral Cavity Squamous Cell CarcinomaStage IV Oropharyngeal Squamous Cell CarcinomaStage IVA Hypopharyngeal Squamous Cell CarcinomaStage IVA Laryngeal Squamous Cell CarcinomaStage IVA Lip and Oral Cavity Squamous Cell CarcinomaStage IVA Oropharyngeal Squamous Cell CarcinomaStage IVB Hypopharyngeal Squamous Cell CarcinomaStage IVB Laryngeal Squamous Cell CarcinomaStage IVB Lip and Oral Cavity Squamous Cell CarcinomaStage IVB Oropharyngeal Squamous Cell CarcinomaStage IVC Hypopharyngeal Squamous Cell CarcinomaStage IVC Laryngeal Squamous Cell CarcinomaStage IVC Lip and Oral Cavity Squamous Cell CarcinomaStage IVC Oropharyngeal Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Lip and Oral Cavity Squamous Cell CarcinomaRecurrent Oropharyngeal SCCRecurrent Paranasal Sinus Squamous Cell Carcinoma
NCT03032250Wake Forest University Health Sciences35